Critical Illness Clinical Trial
Official title:
Non-sedation Versus Sedation With a Daily Wake-up Trial in Critically Ill Patients Receiving Mechanical Ventilation. The NONSEDA-trial. An Investigator-initiated, Randomised, Clinical, Parallel-group, Multinational, Superiority Trial
Background: Every year 30,000 Danish patients are admitted to Intensive Care Units (ICU),
accounting for 2-3% of all patients in hospital and 30% of the yearly hospital expenditure.
The mortality in the ICU is 12.7 % and the 30-day mortality is 21.2 % according to the
national Danish Intensive Care Database. Through many years, the standard care has been to
use continuous sedation of critically ill patients during me-chanical ventilation. However,
recent research indicates that it is beneficial to reduce the sedation level in these
patients. A randomised trial found that continuous sedation with a daily wake-up trial
compared to continuous sedation reduced the time on me-chanical ventilation and the length of
stay in the intensive care unit. Further, a ran-domised trial comparing continuous sedation
with a daily wake-up trial to no sedation found that patients in the non-sedated group needed
mechanical ventilation for a shorter time and had a shorter length of stay in the ICU and in
the hospital. The trial also indicated a beneficial effect on mortality, however the trial
was not a priori de-signed or powered with respect to mortality. No randomised trial has been
published comparing sedation with no sedation, a priori powered to have all-cause mortality
as primary outcome.
Objective: To assess the benefits and harms of non-sedation versus sedation with a daily
wake-up trial in critically ill patients in ICU.
Design: The NONSEDA trial is an investigator-initiated, randomised, clinical, parallel-group,
multinational, superiority trial designed to include 700 patients from at least six ICUs in
Denmark, Norway and Sweden.
Inclusion criteria: Mechanically ventilated patients with expected duration of me-chanical
ventilation > 24 hours.
Exclusion criteria: non-intubated patients, patients with severe head trauma, coma at
admission or status epilepticus, patients treated with therapeutic hypothermia, patients with
PaO2/FiO2<9 where sedation might be necessary to ensure sufficient oxygenation or place the
patient in prone position.
Experimental intervention: Non-sedation supplemented with pain management during mechanical
ventilation.
Control intervention: Sedation with a daily wake-up trial.
The primary hypothesis is that non-sedation compared to sedation and a daily wake-up trial
will reduce mortality.
The secondary hypotheses are that non-sedation compared to sedation and a daily wake-up trial
will:
- Reduce the incidence of a composite outcome of death, acute myocardial in-farction
(AMI), stroke, pulmonary embolism and other thromboembolic events.
- Reduce the number of organ failures.
- Increase the days alive without mechanical ventilation.
- Increase the days alive outside the ICU.
- Increase the days alive outside the hospital.
Outcomes: The primary outcome is all-cause mortality at 90 days. Secondary out-comes are time
to death in the trial period, the frequency of the trombo-embolic com-plications, acute renal
failure, days alive without mechanical ventilation, days alive outside the ICU and hospital.
Explorative outcomes are mortality at 28 days, organ failure and coma-free, delirium-free
days.
Trial size: The investigators will include 700 participants (2 x 350) in order to detect or
reject 25% relative risk reduction in mortality with a type I error risk of 5% and a type II
error risk of 20% (power at 80%).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04551508 -
Delirium Screening 3 Methods Study
|
||
Recruiting |
NCT06037928 -
Plasma Sodium and Sodium Administration in the ICU
|
||
Completed |
NCT03671447 -
Enhanced Recovery After Intensive Care (ERIC)
|
N/A | |
Recruiting |
NCT03941002 -
Continuous Evaluation of Diaphragm Function
|
N/A | |
Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
Completed |
NCT04239209 -
Effect of Intensivist Communication on Surrogate Prognosis Interpretation
|
N/A | |
Completed |
NCT05531305 -
Longitudinal Changes in Muscle Mass After Intensive Care
|
N/A | |
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Completed |
NCT02916004 -
The Use of Nociception Flexion Reflex and Pupillary Dilatation Reflex in ICU Patients.
|
N/A | |
Recruiting |
NCT05883137 -
High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
|
||
Completed |
NCT04479254 -
The Impact of IC-Guided Feeding Protocol on Clinical Outcomes in Critically Ill Patients (The IC-Study)
|
N/A | |
Recruiting |
NCT04475666 -
Replacing Protein Via Enteral Nutrition in Critically Ill Patients
|
N/A | |
Not yet recruiting |
NCT04538469 -
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
|
||
Not yet recruiting |
NCT04516395 -
Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae
|
N/A | |
Withdrawn |
NCT04043091 -
Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction
|
N/A | |
Recruiting |
NCT02922998 -
CD64 and Antibiotics in Human Sepsis
|
N/A | |
Recruiting |
NCT02989051 -
Fluid Restriction Keeps Children Dry
|
Phase 2/Phase 3 | |
Completed |
NCT03048487 -
Protein Consumption in Critically Ill Patients
|
||
Completed |
NCT02899208 -
Can an Actigraph be Used to Predict Physical Function in Intensive Care Patients?
|
N/A | |
Recruiting |
NCT02163109 -
Oxygen Consumption in Critical Illness
|